LINC-ROR and breast cancer: Furthermore, studies on silencing/knockdown of lnc-ROR have confirmed this pathway showing that its inhibition is shown by suppression of invasiveness, migration, reduction in tumor size and reversion of drug resistance in BC cells [218,221,222].